Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2019-09-18 14:39 Tx date 2019-09-13 |
$KLY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$26,306
+526,120 vol $0.05 each |
526,120 | |
Filed 2019-09-18 14:38 Tx date 2016-12-30 |
$KLY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-09-18 14:38 Tx date 2019-09-13 |
$KLY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$26,306
+526,120 vol $0.05 each |
590,561 | |
Filed 2019-06-24 10:03 Tx date 2019-06-19 |
$KLY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+68,698 vol |
4,209,781 | |
Filed 2019-01-28 Tx date 2019-01-25 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+1,129,318 vol |
4,141,083 | |
Filed 2018-09-27 Tx date 2018-09-24 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+1,262,475 vol |
3,011,765 | |
Filed 2018-03-16 Tx date 2018-02-15 |
$RMSP
RMR Science Technologies Inc. |
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-16 Tx date 2018-03-15 |
$RMSP
RMR Science Technologies Inc. |
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+275,000 vol |
275,000 | |
Filed 2018-02-16 Tx date 2018-02-15 |
$
RMR Science Technologies Inc. |
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-02-16 Tx date 2018-02-15 |
$
RMR Science Technologies Inc. |
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$60,000
+1,200,000 vol $0.05 each |
1,200,000 | |
Filed 2018-01-31 Tx date 2018-01-30 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+326,000 vol |
1,749,290 | |
Filed 2017-12-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Rutkowski Family Trust (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+304,764 vol |
||
Filed 2017-12-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Rutkowski Family Trust II (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+304,764 vol |
||
Filed 2017-12-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Rutkowski Family Trust II (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+308,764 vol |
308,764 | |
Filed 2017-12-06 Tx date 2017-10-08 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+1,022,610 vol |
1,423,290 | |
Filed 2017-12-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Rutkowski Family Trust (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+308,764 vol |
308,764 | |
Filed 2017-04-28 Tx date 2011-07-26 |
$BTI
biOasis Technologies Inc. |
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-04-28 Tx date 2017-04-24 |
$BTI
biOasis Technologies Inc. |
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+30,000 vol |
30,000 | |
Filed 2017-04-28 Tx date 2017-04-24 |
$BTI
biOasis Technologies Inc. |
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
800,000 | |
Filed 2017-01-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-01-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+64,441 vol |
64,441 | |
Filed 2017-01-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer
Holder: Rutkowski Family Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-01-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer
Holder: Rutkowski Family Trust (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+304,764 vol |
304,764 | |
Filed 2017-01-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer
Holder: Rutkowski Family Trust II (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-01-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer
Holder: Rutkowski Family Trust II (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+304,764 vol |
304,764 | |
Filed 2017-01-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-01-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+193,808 vol |
193,808 | |
Filed 2017-01-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+206,872 vol |
400,680 | |
Filed 2016-04-14 Tx date 2016-04-10 |
$BTI
biOasis Technologies Inc. |
Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
675,000 |